Current Main Topics in Multiple Myeloma
Multiple Myeloma (MM) remains a difficult to treat disease mainly due to its biological heterogeneity, of which we are more and more knowledgeable thanks to the development of increasingly sensitive molecular methods that allow us to build better prognostication models. The biological diversity tran...
Main Authors: | Sonia Morè, Laura Corvatta, Valentina Maria Manieri, Attilio Olivieri, Massimo Offidani |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/8/2203 |
Similar Items
-
Novel Immunotherapies and Combinations: The Future Landscape of Multiple Myeloma Treatment
by: Sonia Morè, et al.
Published: (2023-11-01) -
Advances in Emerging Therapies for Multiple Myeloma
by: QIAN Chenjing, et al.
Published: (2023-03-01) -
The Role of Monoclonal Antibodies in the Era of Bi-Specifics Antibodies and CAR T Cell Therapy in Multiple Myeloma
by: Meera Mohan, et al.
Published: (2021-09-01) -
Immunotherapy with Antibodies in Multiple Myeloma: Monoclonals, Bispecifics, and Immunoconjugates
by: Christie P. M. Verkleij, et al.
Published: (2021-03-01) -
Monoclonal Antibodies to Treat Multiple Myeloma: A Dream Come True
by: Mattia D’Agostino, et al.
Published: (2020-11-01)